Amylyx Pharmaceuticals, Inc. ($AMLX)
Filing Information
| Accession Number | 0001193125-26-098437 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 9, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
622,160
Total Value
$0.00
P&L
+inf% (+$8,592,029.60)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Mar 5, 2026 | Grant/Award | 248,865 | $0.00 | $0.00 | 3,583,481 | Direct | โ | View Details | |
Director | Stock Option (Right to Buy) | Derivative | Mar 5, 2026 | Grant/Award | 373,295 | $0.00 | $0.00 | 373,295 | Direct | โ | View Details |